Advertisement

Topics

XenoPort Company Profile

01:15 EDT 24th March 2019 | BioPortfolio

We are a biopharmaceutical company focused on developing a portfolio of internally discovered product candidates for the potential treatment of central nervous system (CNS) disorders. We also have a product candidate for the potential treatment of gastroesophageal reflux disease, or GERD. Our drug discovery efforts focus on utilizing the body's natural nutrient transporter mechanisms to improve the therapeutic benefits of drugs. Our most advanced product candidate is being developed for the potential treatment of restless legs syndrome, or RLS, and the management of neuropathic pain. Our second product candidate is being evaluated for the potential treatment of GERD. Each of our product candidates is an orally available, patentable new chemical entity that addresses large potential markets. Our innovative product candidates, which we refer to as Transported Prodrugs, are created by modifying the chemical structure of currently marketed drugs, referred to as parent drugs, and are designed to correct deficiencies in the oral absorption, distribution and/or metabolism of the parent drug. We have designed our current Transported Prodrugs to be actively transported from the gastrointestinal, or GI, tract into the bloodstream, where they are metabolized to release the parent drug. We have licensed rights to develop and commercialize our lead product candidate, XP13512, to Astellas Pharma Inc. in Japan and five other Asian countries and to GlaxoSmithKline in all countries of the world other than the Astellas territory. We hold all worldwide commercial rights to our other product candidates.

Location

3410 Central Expressway
Santa Clara
California
95051
United States of America

Contact

Phone: 408-616-7200
Email: BD@XenoPort.com


News Articles [0 Results]

None

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [2 Associated Companies listed on BioPortfolio]

XenoPort, Inc.

XenoPort, Inc. is a biopharmaceutical company focused on developing a portfolio of internally discovered product candidates that utilize the body’s natural nutrient transport...

XenoPort

We are a biopharmaceutical company focused on developing a portfolio of internally discovered product candidates for the potential treatment of central nervous system (CNS) disorders. We also have a p...

More Information about "XenoPort" on BioPortfolio

We have published hundreds of XenoPort news stories on BioPortfolio along with dozens of XenoPort Clinical Trials and PubMed Articles about XenoPort for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of XenoPort Companies in our database. You can also find out about relevant XenoPort Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...

Barrett's Esophagus
Barrett’s esophagus is a condition in which the tissue lining the esophagus—the muscular tube that carries food and liquids from the mouth to the stomach—is replaced by tissue that is similar to the intestinal lining. This process is ca...


Corporate Database Quicklinks



Searches Linking to this Company Record